Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies

Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies

(2013) Yeon-Joo Lee et al.   MEDICAL MYCOLOGY

Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections

(2012) Natalie K. Boyd et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity

(2012) Dimitra Mitsani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

(2012) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections

(2012) Andres Pascual et al.   CLINICAL INFECTIOUS DISEASES

Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies

(2012) Martin Hoenigl et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Evaluation of the effect of obesity on voriconazole serum concentrations

(2012) E. Koselke et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies

(2012) M. Hoenigl et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients

(2012) Martin Hoenigl et al.   JOURNAL OF INFECTION

Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients

(2012) Alicia Gómez-López et al.   MEDICAL MYCOLOGY

Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies

(2012) Martin Hoenigl et al.   MEDICAL MYCOLOGY

Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience

(2012) Zdenek Racil et al.   MYCOSES

Population Pharmacokinetics of Voriconazole in Adults

(2011) William W. Hope   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

(2011) Peter F. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients

(2011) Si-Hyun Kim et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring

(2011) Arwa Hassan et al.   THERAPEUTIC DRUG MONITORING

Therapeutic Drug Monitoring of Voriconazole in Children

(2011) Jennifer Chen et al.   THERAPEUTIC DRUG MONITORING

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

(2010) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation

(2009) S. M. Trifilio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

(2009) Alain Li-Wan-Po et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Voriconazole Pharmacokinetics and Pharmacodynamics in Children

(2009) Michael Neely et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole concentrations and outcome of invasive fungal infections

(2009) S. Miyakis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES